Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» U.S. Patent Office Revises Guidelines After Drugmakers Complain
U.S. Patent Office Revises Guidelines After Drugmakers Complain
U.S. Patent Office Revises Guidelines After Drugmakers Complain
Submitted by
admin
on December 16, 2014 - 7:48pm
Source:
WSJ Pharmalot
News Tags:
US Patent Office
Myriad Genetics
Headline:
U.S. Patent Office Revises Guidelines After Drugmakers Complain
Do Not Allow Advertisers to Use My Personal information
